Vivo Opportunity, LLC - Jan 31, 2022 Form 4 Insider Report for Sierra Oncology, Inc. (SRRA)

Role: 10%+ Owner
Signature: /s/ Gaurav Aggarwal, as a managing member of Vivo Opportunity, LLC
Stock symbol: SRRA
Transactions as of: Jan 31, 2022
Transactions value $: $21,600,000
Form type: 4
Date filed: 1/31/2022, 08:30 PM
Previous filing: Jan 28, 2022
Next filing: Jul 1, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SRRA	Common Stock	Purchase	$21.6M	+800K	+41.33%	$27.00	2.74M	Jan 31, 2022	By Vivo Opportunity Fund, L.P.	F1
holding	SRRA	Common Stock						162K	Jan 31, 2022	By: Vivo Ventures Fund VII, L.P. and Vivo Ventures VII Affiliates Fund, L.P.
holding	SRRA	Common Stock						432K	Jan 31, 2022	By: Vivo Capital Fund IX, L.P.

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Vivo Opportunity, LLC is the general partner of Vivo Opportunity Fund, L.P., the record holder of the securities. Gaurav Aggarwal, Hongbo Lu, Kevin Dai, Frank Kung and Michael Chang are managing members of Vivo Opportunity, LLC and may be deemed to share voting and dispositive power over the securities held by Vivo Opportunity Fund, L.P. Each of these individuals disclaims beneficial ownership over such securities except to the extent of his or her pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.

Content

Vivo Opportunity, LLC is the general partner of Vivo Opportunity Fund, L.P., the record holder of the securities. Gaurav Aggarwal, Hongbo Lu, Kevin Dai, Frank Kung and Michael Chang are managing members of Vivo Opportunity, LLC and may be deemed to share voting and dispositive power over the securities held by Vivo Opportunity Fund, L.P. Each of these individuals disclaims beneficial ownership over such securities except to the extent of his or her pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.